phenyl acetate has been researched along with Clinical Deterioration in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Braciale, T; Gentile, MA; Groote, F; Hernandez, C; Jabbour, SK; Khan, AR; Kim, S; Malhotra, J; Mehnert, J; Michel, C; Misdary, C; Narayanan, N; Radbel, J; Salgame, P; Siddiqui, S; Yegya-Raman, N | 1 |
1 other study(ies) available for phenyl acetate and Clinical Deterioration
| Article | Year |
|---|---|
Montelukast in hospitalized patients diagnosed with COVID-19.
Topics: Acetates; Asthma; Clinical Deterioration; COVID-19 Drug Treatment; Cyclopropanes; Humans; Leukotriene Antagonists; Prospective Studies; Quinolines; Retrospective Studies; SARS-CoV-2; Sulfides; Treatment Outcome | 2022 |